Setting off in the pharmaceutical sector in 2005 as a pure Greek pharmaceutical company, we knew that the future would be an exciting "journey" for us. Not only because our engagement with Human Health constitutes a very sensitive field of entrepreneurship, but because, beyond the high quality of our product, one of our main goals was also the pursuit for new sources of innovation and creativity.
In our multi-year journey, Bennett has evolved into an ultra-modern pharmaceutical industry, remaining, however, loyal and committed to its principles, mentality and philosophy.
Our basic strategic choice to be active in the entire scope of the pharmaceutical field with Greek branded products of high standards, quality, safety and a variety of therapeutic applications, is the touchstone of our current establishment as one of the most dynamically developing Greek pharmaceutical companies.
Despite intense challenges and competition, in a global economic environment urging for rationalization of pharmaceutical expense, Bennett emerges as a mature and experienced company, with a significant annual increase in turnover, investments in new offices infrastructure and industrial production facilities, creation of new working positions and a significant contribution to the national economy.
At the same time, with Greece as a starting point, we are implementing a rich export activity plan, proving our ability to enter international markets, developing strategic partnerships on a global level.
At Bennett we face the future with enthusiasm, investing methodically in our employees and in core values such as responsibility, integrity, continuous improvement, respect and social contribution, open communication and transparency, creating a new vision for an upgraded way of communicating with patients. With its excellent products, Bennett inspires trust and safety in society and ensures that Health will always be in "good hands". The patients' and Health Professionals' everyday recognition give us prompting and the energy to welcome the next decades with further Health investments and offerings to society as a whole.
Nikos Boufidis, MBA, PhD(c) in Law
President & CEO
Vice President Panhellenic Union of Pharmaceutical Industry